The Cannigma

DECEMBER 4, 2022

THC in 2013 but did not establish a national program. Another draft law was introduced in 2019 to expand the program; as of 2022, it was still in draft in a chamber of government. People who are caught with cannabis for personal use can avoid jail time by participating in an “ integrated assistance program.”

Law 59

Law Seed-To-Sale Programs Tincture 59

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. As part of our continued R&D efforts we also look forward to advancing our PTSD and essential tremor programs, the nabiximols clinical trial program to support a U.S.

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98

Access Patients Chronic Pain Conditions 98

Cannabis Law Report

AUGUST 27, 2021

.’s (NASDAQ: ACB ) (TSX: ACB ) subsidiary Aurora Germany GmbH and Ethypharm have delivered their initial shipment of cannabis to the French medical cannabis pilot program. If successful, this pilot program could lead to one of the largest regulated medical cannabis markets in Europe.”

Patients 105

Patients Programs Pharmaceutical Compliance 105

SpeedWeed

APRIL 9, 2021

Although this survey is specifically focused on Texas’ medical marijuana program, it also supports other research showing that cannabis can serve as an effective replacement for pharmaceuticals. This law allows a limited number of patients to use CBD-based medicine with no more than 0.5 percent THC content.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

The Cannigma

OCTOBER 14, 2022

However, the laws don’t differentiate between soft drugs and hard drugs. San Marino medical marijuana program. Established in 2016 by a citizen’s initiative, patients can purchase cannabis-based medicines like Sativex to treat a number of approved conditions including multiple sclerosis, spine injuries, and neuropathic pain.

Law 56

Law Clinical Trials Research and Development Recreational 56

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. A 2019 study found that 76% of patients in the U.S. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

DECEMBER 9, 2021

08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. as medical consultants to the Company’s DMT stroke clinical research program. In addition to his consulting and directorial responsibilities, he maintains an active research program directed towards improving outcomes for stroke patients. CONTACT INFORMATION.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. So, it shouldn’t be a huge surprise that Virginia didn’t launch a medical marijuana program until 2015, nearly two decades after California.

Marijuana 208

Marijuana Legalization Programs Oil 208

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2 to reach 3.2

Programs 100

Programs Data Events Collective 100

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan. Conclusion.

Access 52

Access Patients Research and Development Treatment 52

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. Today there are 41 states that have enacted some form of a Right to Try or RTT laws. A Push by Patients. Patients Are Not In This Alone.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Veriheal

JULY 21, 2022

This month, patients will no longer require a medical cannabis card to participate in Virginia’s medical cannabis program. Patients no longer need to register through the Board of Pharmacy in order to legally buy medical cannabis in Virginia.

Access 104

Access Dispensary Patients Programs 104

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. The program will be offered for free to Québec physicians and is made possible by an unrestricted educational grant from Spectrum Therapeutics.

Programs 108

Programs Research and Development Education Treatment 108

SpeedWeed

JUNE 14, 2021

State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. The addition of all three, new, medical conditions to the Ohio Medical Marijuana Control Program (OMMCP) is effective immediately.

Conditions 40

Conditions Programs Therapy Patients 40

Cannabis Law Report

DECEMBER 3, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We Webcast to be held Monday, December 6 at 1:00 p.m. ET (12:00 p.m. RADNOR, Pa.–(BUSINESS

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Legislation is pending, Assembly Bill 2355, to protect registered medical marijuana patients from employment discrimination.

Legislation 238

Legislation Patients Decriminalization Access 238

Cannabis Law Report

JANUARY 18, 2022

Texas Original Compassionate Cultivation assembled a focus group of veterans suffering from PTSD to evaluate symptom response, product preference and effects on supplemental pharmaceutical consumption. The focus group consisted of veterans suffering from PTSD who qualify for medical cannabis under the expanded Compassionate Use Program.

Patients 52

Patients Tincture Pharmaceutical Cultivation 52

NORML

JANUARY 24, 2019

It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients. Marijuana policy should be evidence based.

Policy 157

Policy Patients Education Legislation 157

Cannabis Law Report

JUNE 6, 2022

TRC Healthcare (TRC) has launched a new training program to help pharmacists deliver better healthcare for patients who use cannabis products. The online program, known as RxAdvanced: Guide to Cannabis , gives pharmacists a foundational knowledge of cannabis that strengthens their role as stewards of public health. “As

Education 52

Education Research and Development Pharmaceutical Programs 52

Cannabis Law Report

OCTOBER 28, 2021

. “This investment will see Greenlab’s researchers carrying out rigorous trials and lab testing at its leased facilities at Lincoln University to ensure a consistently high-quality and effective pharmaceutical product.”

Programs 52

Programs Research and Development Pharmaceutical Cultivation 52

The Cannigma

JUNE 19, 2022

The country has had a medical cannabis program since 2015. This change in law did not legalize the purchase or sale of cannabis, but it did remove a potential prison sentence of 64 months. Colombia’s medical cannabis program allows for research and product development, as well as prescriptions. Cannabis in Colombia.

Legalization 97

Legalization Decriminalization Research and Development Consumption 97

The Cannigma

JUNE 25, 2022

The country has strict prohibition laws, and violating these can come with fines or hefty jail sentences. Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Poland’s medical cannabis program. Poland and cannabis.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.”

Legalization 86

Legalization Pharmaceutical Therapy Chronic Pain 86

Canna Law Blog

SEPTEMBER 6, 2023

This means that under both state and federal laws, only certain healthcare providers or licensed pharmacists can dispense (or even refill) Schedule III controlled substances. All of those clients have to deal with a myriad of healthcare law and regulatory issues under both federal and state law, and the cost of compliance is not cheap.

Research and Development 113

Research and Development DEA Marijuana Pharmaceutical 113

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. Published Via JD Supra.

Law 105

Law Therapy Clinical Trials Research and Development 105

The NM Political Report | Medical Cannabis Program

JUNE 14, 2022

Michelle Lujan Grisham signed the measure into law, she said in a press release that the bill could “make a real, meaningful difference” by eliminating copays for behavioral health services. The New Mexico Legislature last year approved a bill aimed at eliminating out-of-pocket costs for behavioral health.

Patients 40

Patients Banking Cannabis Treatment 40

NORML

JUNE 13, 2019

Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. All of the state programs are independent and in various stages of maturity. ’s medical marijuana law will start bringing some transparency to consumer-level prices. Voila; Section 705 of Pa.

Marijuana 267

Marijuana Dispensary Patients Cannabinoids 267

Cannabis Law Report

JULY 1, 2021

From their blog… Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative. On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

AUGUST 29, 2021

ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/. The export to Brazil also confirms the regulatory pathway and acts as a proof of concept in the largest market in South America where we aim to establish long-lasting supply relationships with our Brazilian pharmaceutical partners.”.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Veriheal

FEBRUARY 27, 2024

The epidemic was largely driven by pharmaceutical companies who were well aware of the drugs’ dangerous addictive properties but nonetheless encouraged doctors to prescribe them to patients seeking pain relief. The first pharmaceutical company to face substantial consequences is Purdue Pharma. The court cited U.S.

Legalization 62

Legalization Pharmaceutical Law Programs 62

Cannabis Law Report

JULY 28, 2021

The sol-gel technology is designed to deliver pharmaceutical compounds as a liquid at room temperature which becomes a gel at body temperature. atai’s mission is to bridge the gap between what the mental healthcare system currently provides and what patients need. A potential solution is direct nose-to-brain delivery.

Research and Development 98

Research and Development Programs Treatment Media 98

Cannabis Law Report

JULY 26, 2021

OTCQB: SPRCY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced a number of updates regarding its Phase IIb clinical study in Tourette Syndrome using the proprietary cannabinoid-based treatment- SCI-110. About SciSparc (OTCQB: SPRCY): SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105